Keywords: abraxis, signs, deal, products, prometic, usa-based, bioscience
Abraxis signs deal for 4 products with ProMetic
Article | 15 September 2008
USA-based Abraxis BioScience has signed definitive agreements with Canadian biopharmaceutical firm ProMetic Life Sciences for the worldwide development and commercialization ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
